Gensciences develops drugs that focus on underserved illnesses like hemophilia, metabolic diseases, and anti-tumor fields.
Business Model:
Revenue: $0
Employees: 201-500
Address:
City: Nantong
State: Jiangsu
Zip:
Country: China
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | Series A | 3 | - |
Hygeia Capital LLC IDG Capital New Alliance Capital Hygeia Capital LLC IDG Capital New Alliance Capital |
3/2021 | Series B | 3 | - |
EFung Capital Haitong Kaiyuan Investment Huarong Rongde Asset Management EFung Capital Haitong Kaiyuan Investment Huarong Rongde Asset Management |
3/2021 | Series A | 3 | - |
Hygeia Capital LLC IDG Capital New Alliance Capital Hygeia Capital LLC IDG Capital New Alliance Capital |
3/2021 | Series B | 3 | - |
EFung Capital Haitong Kaiyuan Investment Huarong Rongde Asset Management EFung Capital Haitong Kaiyuan Investment Huarong Rongde Asset Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|